➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Express Scripts
Merck
Mallinckrodt
McKinsey

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Patent: 7,700,826

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,700,826
Title:Genes encoding wheat starch synthases and uses thereof
Abstract: The present invention provides isolated nucleic acid molecules encoding wheat starch synthases, and probes and primers derived therefrom, which are useful in the modification of plant starch content and/or composition, and for screening plant lines to determine the presence of natural and/or induced mutations in starch synthase genes which affect starch content and/or composition. More particularly, the isolated nucleic acid molecules of the present invention further provide for the screening-assisted breeding of plants having desirable starch content and/or composition, in addition to providing for the direct genetic manipulation of plant starch content and/or composition.
Inventor(s): Morell; Matthew (Aranda, AU), Li; Zhongyi (Kaleen, AU), Rahman; Sadequr (Melba, AU), Appels; Rudolph (Perth, AU)
Assignee: Commonwealth Scientific and Industrial Ressearch Organization (Campbell, AU) Biogemma SAS (Paris, FR)
Application Number:11/231,599
Patent Claims:see list of patent claims

Details for Patent 7,700,826

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Commonwealth Scientific and Industrial Ressearch Organization (Campbell, AU) Biogemma SAS (Paris, FR) 2019-04-29 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Commonwealth Scientific and Industrial Ressearch Organization (Campbell, AU) Biogemma SAS (Paris, FR) 2019-04-29 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Commonwealth Scientific and Industrial Ressearch Organization (Campbell, AU) Biogemma SAS (Paris, FR) 2019-04-29 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 7,700,826

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Johnson and Johnson
Boehringer Ingelheim
Dow
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.